Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Phenotyping and Follow up of Forty-Seven Iranian Patients With Common Variable Immunodeficiency Publisher Pubmed



Arshi S1 ; Nabavi M1 ; Bemanian MH1 ; Shakeri R2 ; Taghvaei B1 ; Ghalebaghi B1, 3 ; Babaie D4 ; Bahrami A1 ; Fallahpour M1 ; Esmaeilzadeh H5 ; Rekabi M1 ; Amadian J1 ; Eslami N1 ; Shokri S1 Show All Authors
Authors
  1. Arshi S1
  2. Nabavi M1
  3. Bemanian MH1
  4. Shakeri R2
  5. Taghvaei B1
  6. Ghalebaghi B1, 3
  7. Babaie D4
  8. Bahrami A1
  9. Fallahpour M1
  10. Esmaeilzadeh H5
  11. Rekabi M1
  12. Amadian J1
  13. Eslami N1
  14. Shokri S1
  15. Jalali F1
  16. Akbarpour N1
  17. Molatefi R1
  18. Rezaei N6, 7, 8
Show Affiliations
Authors Affiliations
  1. 1. Allergy and Clinical Immunology Department of Rasol-E-Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran
  2. 2. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  3. 3. Research Center of Otolaryngology and Head and Neck Surgery, IUMS, Tehran, Iran
  4. 4. Allergy and Clinical Immunology Department of Mofid Hospital, Shaheed Beheshti University of Medical Sciences (SBMU), Tehran, Iran
  5. 5. Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Molecular Immunology Research Center and Department of Immunology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  7. 7. Research Center for Immunodeficiency, Children's Medical Center, TUMS, Tehran, Iran
  8. 8. Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Allergologia et Immunopathologia Published:2016


Abstract

Background: Common variable immune deficiency (CVID) is a heterogeneous syndrome with a wide variety of signs and symptoms. This study describes the phenotyping and survival of the CVID patients in the allergy and clinical immunology department of Rasol-E-Akram Hospital of Iran University of Medical Sciences in Tehran. Method: We retrospectively reviewed hospital files of CVID patients in our department until January 2014. All patients were diagnosed with standard diagnostic criteria of CVID, treated and visited monthly, during the follow-up period. We divided the patients into four phenotypes; infection only, cytopenia, polyclonal lymphocytic infiltration and unexplained enteropathy. The immunologic, demographic and clinical findings in different phenotypes were analysed. Results: The study included 47 CVID patients with mean age at onset of symptoms and diagnosis of 11.2 and 20.2 years, respectively. Phenotyping of our patients was: only infection (62%), cytopenia (26%) and PLI (19%) and 94% of cases had only one phenotype. We did not find a significant relation between the clinical phenotypes and immunologic or demographic data. Rate of parental consanguinity in our cases was 47%. Parental consanguinity was related to lower age at onset, lower age at diagnosis and higher baseline IgG levels. Patients with malignancy and autoimmunity had significantly higher age at onset. Our patients were followed-up for 6.9 years and the mortality rate during this time was 6%. Conclusions: Parental consanguinity and age at onset of CVID symptoms may have important roles in CVID manifestations. © 2015 SEICAP.
Other Related Docs
16. Autoimmunity in Primary Antibody Deficiencies, International Archives of Allergy and Immunology (2017)
17. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment, Journal of Investigational Allergology and Clinical Immunology (2015)
21. Primary Immunodeficiencies and Cancers, Cancer Immunology: A Translational Medicine Context (2015)
28. Approach to the Management of Autoimmunity in Primary Immunodeficiency, Scandinavian Journal of Immunology (2017)
29. Common Presentations and Diagnostic Approaches, Stiehm's Immune Deficiencies: Inborn Errors of Immunity (2020)
36. Inborn Errors of Immunity and Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
41. The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases, Endocrine# Metabolic and Immune Disorders - Drug Targets (2016)
42. Ataxia Telangiectasia Syndrome: Moonlighting Atm, Expert Review of Clinical Immunology (2017)
43. Asthma and Allergic Diseases in a Selected Group of Patients With Common Variable Immunodeficiency, Journal of Investigational Allergology and Clinical Immunology (2016)
50. A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency, Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)